BFRI
Biofrontera Inc.
+0.05 (+3.78%)1.26USD206K成交股數18.7M市值–本益比(近四季)0.4股價營收比+32.9%營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 12.0M+33% | 10.1M+17% | 17.1M+90% | 7.0M-11% | 9.0M+14% | 8.6M-19% | 9.0M+1% | 7.8M+34% | 7.9M | 10.6M | 8.9M | 5.8M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 448K | 900K | 788K | 854K | 870K | 1.2M | 669K | 621K | 17K | – | 33K | 11K |
| 銷售管理費用 | 9.6M | 11.0M | 8.5M | 10.0M | 10.5M | 8.7M | 8.4M | 7.9M | 9.3M | 9.1M | 8.6M | 11.5M |
| 營業利益 | −524K-90% | −4.3M-5% | 4.6M-192% | −6.3M+24% | −5.1M-7% | −4.5M+18% | −5.0M+7% | −5.1M-42% | −5.5M | −3.9M | −4.6M | −8.7M |
| 營業利益率 | -4.4% | -42.8% | 26.6% | -89.8% | -56.2% | -52.9% | -55.0% | -64.7% | -69.1% | -36.5% | -51.9% | -148.8% |
| 稅後淨利 | −604K-89% | −4.8M+13% | 5.6M-199% | −6.6M+2487% | −5.3M-49% | −4.2M-219% | −5.7M-11% | −257K-97% | −10.4M | 3.5M | −6.3M | −9.8M |
| 淨利率 | -5.0% | -47.1% | 33.0% | -95.1% | -59.0% | -48.9% | -62.9% | -3.3% | -131.9% | 33.3% | -71.3% | -168.2% |
| 稀釋 EPS | -0.05-91% | -0.41-13% | 0.62-163% | -0.62+1140% | -0.57-80% | -0.47-111% | -0.98-79% | -0.05-99% | -2.88 | 4.45 | -4.64 | -7.23 |
| 稀釋股數 | 12.9M | 11.7M | 10.2M | 10.8M | 9.4M | 8.9M | 5.8M | 5.1M | 3.6M | 1.5M | 1.4M | 1.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.7M | 6.3M | 6.4M | 3.4M | 7.2M | 1.8M | 2.9M | 4.4M | 3.8M | 1.3M | 3.4M | 4.5M |
| 應收帳款 | 5.5M | – | 7.3M | – | – | – | – | – | – | – | – | – |
| 存貨 | 1.1M | 1.2M | 1.4M | 4.3M | 4.0M | 6.5M | 6.5M | 3.9M | 6.9M | 10.9M | 16.1M | 14.8M |
| 總資產 | 24.1M | 24.8M | 28.6M | 15.4M | 20.1M | 16.6M | 18.5M | 21.6M | 24.6M | 27.9M | 34.1M | 36.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 18.1M | 18.7M | 18.1M | 18.0M | 24.8M | 16.1M | 13.0M | 10.7M | 26.4M | 23.1M | 33.1M | 29.7M |
| 股東權益 | 6.0M | 6.1M | 10.5M | −2.6M | −4.7M | 469K | 5.5M | 10.9M | −5.4M | 4.8M | 1.0M | 7.2M |
| 負債比 | 75.2% | 75.5% | 63.3% | 116.7% | 123.2% | 97.2% | 70.1% | 49.4% | 107.5% | 82.8% | 97.0% | 80.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −70K-98% | – | – | – | −4.1M | – | – | −3.3M | – | – | – |
| 資本支出 | – | 5K | – | – | – | 3K | – | – | 57K | – | – | – |
| 自由現金流 | – | −75K-98% | – | – | – | −4.1M | – | – | −3.4M | – | – | – |
| 折舊攤銷 | – | 55K | – | – | – | 29K | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -0.7% | – | – | – | -48.0% | – | – | -42.7% | – | – | – |
營收拆解 2021 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2021 年度 · 24.1M
| 產品 | 24.0M | 99.8% | +28.0% |
|---|---|---|---|
| Revenues Related Party | 57K | 0.2% | -8.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 41.7M | +11.7% | −10.5M | -25.3% | -1.04 | −13.4M |
| FY2024 | 37.3M | +9.5% | −17.8M | -47.6% | -3.22 | −10.3M |
| FY2023 | 34.1M | +18.8% | −20.1M | -59.1% | -13.02 | −24.9M |
| FY2022 | 28.7M | +19.3% | −640K | -2.2% | -0.61 | −16.2M |
| FY2021 | 24.0M | +27.6% | −37.7M | -156.9% | -4.28 | – |
| FY2020 | 18.8M | – | −11.0M | -58.3% | -479.48 | – |